Sergei Sergeevich Naumov

Sergei Sergeevich Naumov

Auto-generated profile, based on publicly available information

Sergei Sergeevich Naumov

Siberian State Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2021 in EXCLI Journal
Verified
Journal Article
Open access
VUVladimir Vasil'EVich Udut
Vladimir Vasil'EVich Udut
SNSergei Alexandrovich Naumov
Sergei Alexandrovich Naumov
DEDiana Nikolaevna Evtushenko
Diana Nikolaevna Evtushenko
UEUdut Elena
Udut Elena
SNSergei Sergeevich Naumov
Sergei Sergeevich Naumov
GZGleb Nikolaevich Zyuz'KOv
Gleb Nikolaevich Zyuz'KOv
Acute respiratory distress syndrome (ARDS) is the main danger to the life of patients with pneumonia caused by SARS-CoV-2. At the same time, respiratory failure (RF) after ARDS can persist for a long time despite intensive therapy. Therefore, it is important to develop new effective approaches for restoring the ventilation function of the lungs after COVID-19. Here, we present a case report of effective application of short-term inhalations of xenon-oxygen (Xe/O2) gas mixture for treatment of RF and neuropsychiatric disorders (NPD) associated with COVID-19. The patient inhaled a gas mixture of 70 % Xe and 30 % O2. We used multispiral computed tomography, evaluated psychometry, studied hematological and biochemical blood parameters, and applied some other methods of clinical studies to assess the therapeutic effectiveness of Xe inhalation. Also, we studied the mechanism of action of xenon with computer modeling. The clinical case showed the high efficacy of Xe/O2 mixture for treating severe RF and NPD after SARS-CoV-2 infection. Xenon inhalations dramatically increased oxygen saturation and the degree of pneumatization of the lungs. We found out that in coronavirus pneumonia, saturated phospholipids of surfactant are transferred to the solid-ordered phase, which disrupts the surface tension of the alveoli and alveolar gas exchange. Using molecular modeling methods, we demonstrated that the xenon atom increases the distance between the acyl chains of phospholipids due to the van der Waals dispersion interaction. These changes allow for the phase transition of phospholipids from the solid-ordered phase to the liquid phase and restore the functional activity of the surfactant. The findings suggest the feasibility of conducting studies on the effectiveness of Xe/O2 inhalations for treating ARDS in SARS-CoV-2 infection.

26 July 2023 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
SNSergei S. Naumov
Sergei S. Naumov
DKDenis kulbakin
Denis kulbakin
NKNadezhda V. Krakhmal
Nadezhda V. Krakhmal
SVSergey V Vtorushin
Sergey V Vtorushin

16 July 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
NKNadezhda V. Krakhmal
Nadezhda V. Krakhmal
MTM. I. Taranenko
M. I. Taranenko
SNS. S. Naumov
S. S. Naumov
SVSergey V Vtorushin
Sergey V Vtorushin

23 January 2024 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
SNS. S. Naumov
S. S. Naumov
NKNadezhda V. Krakhmal
Nadezhda V. Krakhmal
MTM. N. Tarasov
M. N. Tarasov
MTM. I. Taranenko
M. I. Taranenko
UEUdut Elena
Udut Elena
SVSergey V Vtorushin
Sergey V Vtorushin
Aim. To conduct a clinical and morphological assessment of the characteristics of colon cancer depending on the dMMR / pMMR status of the tumor.Materials and methods. A retrospective study included 66 patients with operable colorectal cancer (CRC) (T1-4bN0-2bM1), who were treated at Cancer Research Institute of Tomsk National Research Medical Center (NRMC). The average age of the patients was 64.4 ± 12.8 years. All patients underwent hemicolectomy or colon resection, as well as intraoperative resection of distant metastases, if present.Results. We determined that in CRC patients with pMMR tumors, hematogenous metastases were detected in 27.3% of cases, while in patients with dMMR tumors, hematogenous metastases were detected only in 6.1% of cases (p = 0.021). A comparative analysis of dMMR and pMMR tumors also allowed to establish higher frequency of perineural invasion among the pMMR subgroup of carcinomas (p = 0.039). The sign of tumor budding was found both in dMMR carcinomas (36%) and in pMMR tumors (45%). This sign was associated with damage to regional lymph nodes (p = 0.0017). A more detailed analysis of the tumor budding phenomenon showed that in dMMR tumors, Bd1 low-grade budding (83%) predominated. In pMMR tumors, Bd2 intermediate-grade budding (33%) and Bd3 high-grade budding (26.7%) prevailed. Bd2 and Bd3 tumor budding types were associated with hematogenous metastasis (p < 0.001).Conclusion. The obtained data demonstrate the differences in such pathomorphological parameters as perineural invasion and the degree of tumor budding depending on the dMMR / pMMR status of the tumor. These histologic parameters in tumor tissue are also associated with higher incidence of distant metastasis in patients with pMMR carcinomas as opposed to patients with dMMR tumors.

6 March 2021 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
SVSergey V Vtorushin
Sergey V Vtorushin
SNS. S. Naumov
S. S. Naumov
Ivan V. StepanovIvan V. Stepanov
Ivan V. Stepanov
LSL. E. Sinyansky
L. E. Sinyansky
SASergey G. Afanasyev
Sergey G. Afanasyev
The purpose of the study was to analyze and summarize data regarding a significance of PD -L1 expression in various molecular subtypes of colorectal cancer.Material and Methods. A systemic literature search was conducted in the electronic databases Medline, Cochrane Library, Elibrary, PubMed. Of identified and reviewed 201 full-text articles, we included data from 47 studies.Results. The literature review described the features of the molecular genetic classification of colorectal cancer and revealed the key characteristics of each of the molecular subtypes of this disease. Much attention was paid to the molecular mechanisms of anti-PD -1/PD -L1 therapy. The main problems associated with the standardization of methods for pathomorphological assessment of the expression of this marker and the difficulties of its interpretation in colorectal carcinomas were outlined.Conclusion. Analysis of the literature revealed problems associated with the assessment of PD -L1 expression in colorectal cancer, in particular, with the lack of generally accepted methods for interpreting research results and standardizing methods for pathomorphological diagnosis of malignant tumors of this localization. Further studies are needed for introducing the molecular genetic classification of colorectal carcinomas into a wide clinical practice and personalizing the approach to therapy of this disease.

3 September 2022 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
LSL. E. Sinyanskiy
L. E. Sinyanskiy
NKNadezhda V. Krakhmal
Nadezhda V. Krakhmal
SNS. S. Naumov
S. S. Naumov
SPS. V. Patalyak
S. V. Patalyak
SASergey G. Afanasyev
Sergey G. Afanasyev
SVSergey V Vtorushin
Sergey V Vtorushin
The treatment of colon cancer with a mesenchymal-like phenotype poses a great challenge. Purpose of the study: to research expression of FRMD6, ZEB1, HTR2B, CDX2 in the primary tumor tissue with relation of the clinical and pathological features of colon cancer. Material and methods. a combined analysis of the expression of FRMD6, ZEB1, HTR2B, CDX2 with pathological criteria was performed in 100 patients with T1–4bN0–2bM0 colon cancer. Results of the study show that tumors with mesenchymal signs are characterized by a large size of the primary tumor, a high grade of differentiation, regional metastases, and eventually advanced stage of the disease. The frequency and expression levels of FRMD6, ZEB1 and HTR2B are depended of grade of adenocarcinoma. in cases with positive expression and a high percentage of expression of these proteins in the cancer cells, the degree of tumor morphological anaplasia increases. Conclusion. The study made it possible to reveal the relationship of IHC markers (FRMD6, ZEB1, HTR2B, CDX2) with tumor characteristics that determine the outcome. The studied markers may have prognostic and predictive value in treatment approaches of colon cancer.